(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)
Adding Ebola to the FDA Priority Review Voucher Program Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to add filoviruses, a family of viruses that includes the Ebola virus, to the list of tropical diseases under the priority review voucher program, which awards vouchers to sponsors of human drug applications that are approved to prevent or treat tropical diseases. (A voucher entitles the holder to have a future human drug application acted upon by the Food and Drug Administration (FDA) within six months.)
Changes the process by which infectious diseases that do not significantly impact developed nations and disproportionately affect poor and marginalized populations can be designated as tropical diseases from rulemaking to order of the Secretary of Health and Human Services (HHS).
Allows priority review vouchers to be transferred between sponsors of human drug applications any number of times.
Reduces from 365 days to 90 days the advance notice required before submitting a human drug application subject to a priority review voucher.Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin without amendment. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 602.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S6271; text as passed Senate: CR S6271)
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6271; text as passed Senate: CR S6271)
Received in the House.
Message on Senate action sent to the House.
Held at the desk.
Mr. Bilirakis asked unanimous consent to take from the Speaker's table and consider.
Considered by unanimous consent. (consideration: CR H8344)
Passed/agreed to in House: On passage Passed without objection.(text: CR H8344)
On passage Passed without objection. (text: CR H8344)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 113-233.
Became Public Law No: 113-233.
Enacted as Public Law 113-233
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line